H. Wilton-Clark

Natural History of a Mouse Model Overexpressing the Dp71 Dystrophin Isoform

K. Lim, Md Nur Ahad Shah, Stanley Woo, 2021, International journal of molecular sciences.

Casimersen for Duchenne muscular dystrophy.

H. Wilton-Clark, T. Yokota, 2021, Drugs of today.

Biological therapies for the treatment of Duchenne muscular dystrophy.

H. Wilton-Clark, T. Yokota, 2022, Expert opinion on biological therapy.

Antisense and Gene Therapy Options for Duchenne Muscular Dystrophy Arising from Mutations in the N-Terminal Hotspot

H. Wilton-Clark, T. Yokota, 2022, Genes.

Recent Trends in Antisense Therapies for Duchenne Muscular Dystrophy

H. Wilton-Clark, T. Yokota, 2023, Pharmaceutics.

CRISPR-Cas9-mediated exon skipping as a cardioprotective strategy in Duchenne muscular dystrophy

H. Wilton-Clark, T. Yokota, Toshifumi Yokota, 2023, Molecular therapy. Methods & clinical development.

Advancing Epidemiology and Genetic Approaches for the Treatment of Spinal and Bulbar Muscular Atrophy: Focus on Prevalence in the Indigenous Population of Western Canada

H. Wilton-Clark, T. Yokota, Ammar Al-aghbari, 2023, Genes.

Preparing for Patient-Customized N-of-1 Antisense Oligonucleotide Therapy to Treat Rare Diseases

H. Wilton-Clark, Toshifumi Yokota, Eric Yan, 2024, Genes.